Chemotactic cytokine receptor 5 (CCR5) gene promoter polymorphism (59029A/G) is associated with diabetic nephropathy in Japanese patients with type 2 diabetes: A 10-year longitudinal study

Diabetes Research and Clinical Practice

Volumn 73, Issue 1, 2006, Pages 89-94

  Mokubo, Atsuko ^a   Tanaka, Yasushi ^b   Nakajima, Kunihiro ^b   Watada, Hirotaka ^b   Hirose, Takahisa ^b   Kawasumi, Masahiko ^b   Sakai, Ken ^b   Kanazawa, Akio ^b   Maeda, Shiro ^c   Hosokawa, Kazuhiro ^a   Atsumi, Yoshihito ^a   Matsuoka, Kenpei ^a   Kawamori, Ryuzo ^b  

^a SAISEIKAI CENTRAL HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

CCR5; Chemotactic cytokine; Diabetes; Nephropathy; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR5; RANTES;

ADULT; AGED; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JAPAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PROMOTER REGION; PROTEIN LOCALIZATION; PROTEINURIA; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOKINE CCL5; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; RANTES; RECEPTORS, CCR5; RETROSPECTIVE STUDIES;

EID: 33747185164     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.12.006     Document Type: Article

References (23)

1. Furuta T., Saito T., Ootaka T., Soma J., Obara K., Abe K., et al. The role of macrophages in diabetic glomerulosclerosis. Am. J. Kidney Dis. 21 (1993) 480-485
2. Sassy-Prigent C., Heudes D., Mandet C., Belair M.F., Michel O., Perdereau B., et al. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Kidney Int. 51 (2000) 610-621
3. Chow F., Ozols E., Nikolic-Paterson D.J., Atkins R.C., and Tesch G.H. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 65 (2004) 116-128
4. Hasegawa G., Nakano K., Sawada M., Uno K., Shibayama Y., Ienaga K., et al. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int. 40 (1991) 1007-1012
5. Schlodorff D., Nelson P.J., Luckow B., Bariety J., and Bruneval P. Chemokine and renal disease, chemokine and renal disease. Kidney Int. 51 (1997) 610-621
6. Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277 (1997) 959-965
7. McDermott D.H., Zimmerman P.A., Guignard F., Kleeberger C.A., Leitman S.F., and Murphy P.M. CCR5 promoter polymorphism and HIV-1 disease progression. Lancet 352 (1998) 866-870
8. Nakajima K., Tanaka Y., Nomiyama T., Ogihara T., Piao L., Sakai K., et al. Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes. Diabetes 51 (2002) 238-242
9. Liu H., Chao D., Nakayama E.E., Taguchi H., Goto M., Xin X., et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 4581-4585
10. al Shari F., Ollier W.E., and Hajeer A.H. A rare polymorphism at position -28 in the human RANTES promoter. Eur. J. Immunogenet. 26 (1999) 373-374
11. Nakajima K., Tanaka Y., Nomiyama T., Ogihara T., Ikeda F., Kanno R., et al. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diab. Care 26 (2003) 892-898
12. American Diabetes Association. Diabetic nephropathy. Diab. Care 26 Suppl. (2003) S94-S97
13. UK Prospective Diabetes Study Group, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38, BMJ 317 (1998) 703-713.
14. Schichiri M., Kishikawa H., Ohkubo Y., and Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diab. Care 23 Suppl. 2 (2000) B21-B29
15. Gaede P., Vedel P., Larsen N., Jensen G.V., Parving H.H., and Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 30 (2003) 383-393
16. Abdi R., Tran T.B., Sahagun-Ruiz A., Murphy P.M., Brenner B.M., Milford E.L., et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J. Am. Soc. Nephrol. 13 (2002) 754-758
17. Grone H.J., Weber C., Weber K.S., Grone E.F., Rabelink T., Klier C.M., et al. Met-RANTES reduces vascular and tubular damage during acute renal transplantation: blocking monocyte arrest and recruitment. FASEB J. 13 (1999) 1371-1383
18. Song E., Zou H., Yao Y., Proudfoot A., Antus B., Liu S., et al. Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int. 61 (2002) 676-685
19. Shieh B., Liau Y.E., Hsieh P.S., Yan Y.P., Wang S.T., and Li C. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. Int. Immunol. 12 (2000) 1311-1318
20. Schecter A.D., Calderon T.M., Berman A.B., McManus C.M., Fallon J.T., Rossikhina M., et al. Human vascular smooth muscle cells possess functional CCR5. J. Biol. Chem. 275 (2000) 5466-5471
21. Veillard N.R., Kwak B., Pelli G., Mulhaupt F., James R.W., Proudfoot A.E., et al. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ. Res. 94 (2004) 253-261
22. Kawamori R., Yamasaki Y., Matsuhisa M., Nishizawa H., Nao K., Hougaku H., et al. Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolutional B-mode imaging on carotid arteries. Diab. Care 15 (1992) 1290-1294
23. Yamasaki Y., Kodama M., Nishizawa H., Sakamoto K., Matsuhisa M., Kajimoto Y., et al. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diab. Care 23 (2000) 1310-1315